Location History:
- Velletri, IT (2002 - 2011)
- Rome, IT (2006 - 2016)
- Pomezia, IT (2011 - 2022)
Company Filing History:
10 out of 47 
8 out of 2,405 
2 out of 11 
Years Active: 2002-2022
Title: Vincenzo Summa: A Pioneer in Biomedical Innovation
Introduction:
Vincenzo Summa, based in Rome, Italy, is a highly accomplished inventor and scientist specializing in the fields of biotechnology and pharmaceuticals. With an impressive portfolio of 28 patents and a remarkable track record, Summa has made significant contributions to the medical community. This article delves into Summa's latest patents, career highlights, notable collaborations, and his impact on the field of innovation.
Latest Patents:
Among his notable recent patents, Vincenzo Summa has developed groundbreaking tricyclic inhibitors of Hepatitis B virus (HBV). These compounds are highly effective in treating, ameliorating, preventing, and curing HBV infections and related conditions. The invention not only demonstrates a new avenue for HBV treatment but also opens possibilities for the development of novel pharmaceutical compositions.
Furthermore, Summa has made significant strides in the fight against kinetoplastid infections, another major health concern. His inventive class of heterocyclic compounds shows promise for treating kinetoplastid infections. By developing pharmaceutical compositions with these compounds, Summa presents new possibilities for combating these challenging diseases.
Career Highlights:
Vincenzo Summa's illustrious career spans several reputable organizations. He has worked at renowned institutions, such as Istituto Di Ricerche Di Biologia Molecolare P. Angeletti SpA and Merck Sharp & Dohme Corporation (Merck). Summa's contributions within these organizations have been instrumental in advancing biomedical research and innovation.
At Istituto Di Ricerche Di Biologia Molecolare P. Angeletti SpA, Summa had the opportunity to delve into various aspects of biotechnology research. His work helped lay the foundation for groundbreaking discoveries and contributed to the institution's reputation as a center of excellence.
Summa's tenure at Merck Sharp & Dohme Corporation further solidified his expertise in pharmaceutical research and development. His innovative thinking and dedication to scientific progress played a crucial role in the company's advancement within the healthcare industry.
Collaborations:
Throughout his career, Vincenzo Summa has collaborated with esteemed professionals and researchers, expanding his knowledge and broadening the impact of his inventions. Notably, he has collaborated with Steven Harper and Paola Pace, both renowned figures in the field of biotechnology. These collaborations have resulted in synergistic efforts and fruitful outcomes that have pushed the boundaries of scientific knowledge and practical applications.
Conclusion:
Vincenzo Summa's contributions to the field of biomedical innovation and patenting are both impressive and influential. His groundbreaking patents for inhibitor compounds against Hepatitis B virus and kinetoplastid infections have the potential to revolutionize patient care and treatment in these areas. With a rich career history and collaborations with esteemed professionals, Summa's impact on the field of innovation remains significant. As we eagerly anticipate his future advancements, the scientific community is certain to benefit from his groundbreaking work aimed at improving human health and well-being.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.